Alzheimer Disease: all 3,765 studies
Page 35 of 38. Open to participants first (881), then studies with results posted, then the rest; newest registration first within each.
- A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)CompletedNCT00757939Phase 1
- Deep Transcranial Magnetic Stimulation in Patients With Alzheimer's DiseaseStatus unknownNCT00753662Phase 2
- Cerebral and Peripheral Perfusion Pilot StudyCompletedNCT00751907Phase 2
- Alzheimer and SleepCompletedNCT00750529Phase 1
- Solanezumab Safety Study in Japanese Patients With Alzheimer's DiseaseCompletedNCT00749216Phase 2
- Study Evaluating The Potential Interaction Between Verapamil Immediate Release And SAM-531 When Co-AdministeredCompletedNCT00745576Phase 1
- Pilot Study of the Effects of Resveratrol Supplement in Mild-to-moderate Alzheimer's DiseaseWithdrawnNCT00743743Phase 3
- Tracking Technologies for the Analysis of Mobility in Alzheimer's DiseaseStatus unknownNCT00743418Phase 1/2
- Study Evaluating PAZ-417 in Cerebrospinal Fluid in Subjects With Alzheimer's DiseaseTerminatedNCT00739037Phase 1
- A Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's DiseaseCompletedNCT00736775Phase 1
- Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients.CompletedNCT00733863Phase 2
- PK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy VolunteersCompletedNCT00733785Phase 1
- Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's DiseaseCompletedNCT00733642Phase 1
- Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.CompletedNCT00731224Phase 4
- Drug Interaction Study With a Potential Alzheimer's Disease CompoundCompletedNCT00726726Phase 1
- Study Evaluating Safety, Tolerability and Pharmacokinetics of Single and Multiple Dose of SAM-531CompletedNCT00726115Phase 1
- Telephone Resources and Assistance for Caregivers (TRAC)CompletedNCT00721383Not applicable
- Study Evaluating Safety of GSI 136 in Young and Elderly Japanese MalesCompletedNCT00719394Phase 1
- Study GSI-136 in Healthy Young and Healthy Elderly SubjectsCompletedNCT00718731Phase 1
- A Pilot Study of Inflammatory Markers in Alzheimer's DiseaseStatus unknownNCT00715858Phase 3
- Pharmacokinetic Interaction Between AZD3480 and DonepezilTerminatedNCT00713765Phase 1
- Long-term Safety and Tolerability of AFFITOPE AD02CompletedNCT00711321
- Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's DiseaseWithdrawnNCT00711204Phase 4
- Long-term Safety and Tolerability of AFFITOPE AD01CompletedNCT00711139
- Safety and Feasibility of Sodium Oxybate in Mild Alzheimer's Disease PatientsTerminatedNCT00706186Phase 4
- Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's DiseaseTerminatedNCT00704782Phase 2
- Memantine on Aggression and Agitation of Alzheimer's Disease (AD)Status unknownNCT00703430Not applicable
- Observational Study on Costs and Caregiver Burden in Alzheimer's DiseaseCompletedNCT00698165
- Study of PRX-03140 Monotherapy in Subjects With Alzheimer's DiseaseTerminatedNCT00693004Phase 2
- Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for β AmyloidCompletedNCT00692705Phase 1
- MRI to Measure Treatment With Antibiotics in Alzheimer's DiseaseCompletedNCT00692588
- Drug Interaction Study Between AZD3480 and Cytochrome P450CompletedNCT00692510Phase 1
- Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Alzheimer's DiseaseWithdrawnNCT00691340
- Drug Interaction Study Between AZD3480 and WarfarinCompletedNCT00689637Phase 1
- Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy SubjectsCompletedNCT00689559Phase 1
- Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR)CompletedNCT00688207Phase 1
- Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy SubjectsCompletedNCT00687141Phase 1
- Open Label Study of TRx0014 in Alzheimer's DiseaseCompletedNCT00684944Phase 2
- Study Evaluating the Safety, Tolerability and Activity of One Dose of PAZ-417 Given to Healthy Japanese SubjectsCompletedNCT00684710Phase 1
- Early Diagnosis of Alzheimer's Disease: Clinical, Neuropsychological and Neuroimaging Follow-up of a Cohort of Patients With an Isolated Memory ImpairmentCompletedNCT00684281Not applicable
- Randomized Trial of a Nutritional Supplement in Alzheimer's DiseaseCompletedNCT00678431Phase 3
- P-glycoprotein Function in Brain DiseasesCompletedNCT00677885
- A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's DiseaseCompletedNCT00675623Phase 3
- Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's DiseaseCompletedNCT00675090Phase 1
- A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of DonepezilTerminatedNCT00672945Phase 2
- Improved Diagnosis of Alzheimer's Disease Using the Synchronous Neural Interaction™ TestCompletedNCT00666445
- Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's DiseaseCompletedNCT00663936Phase 2
- Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy ElderlyCompletedNCT00660088
- Deep Brain Stimulation (DBS) for Alzheimer's DiseaseCompletedNCT00658125Not applicable
- Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-amyloid Protein DepositionTerminatedNCT00657813Phase 1
- Memory Disorders RegistryCompletedNCT00654563
- System-IGF-1 Pathway and Alzheimer's DiseaseCompletedNCT00647478
- Efficacy Assessment of Three Non Pharmacological Therapies in Alzheimer's DiseaseCompletedNCT00646269Phase 3
- Self- Care TALK Study - Promoting Alzheimer's Disease (AD) Spousal Caregiver HealthCompletedNCT00646074Not applicable
- A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's DiseaseCompletedNCT00645190Phase 3
- Continuous Arterial Spin Labeling (CASL) MRI for Monitoring and Prediction of Drug Therapy in Alzheimers Disease (AD)Status unknownNCT00637442Not applicable
- Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's DiseaseCompletedNCT00633841Phase 1
- A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing HomesCompletedNCT00630851Phase 3
- Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)CompletedNCT00630500Phase 2
- Preliminary Study of Fish Oil and DementiaCompletedNCT00628017Not applicable
- Rivastigmine in Mild Alzheimer's Disease, FMRI StudyCompletedNCT00627848Not applicable
- Evaluation of Programs of Coordinated Care and Disease ManagementStatus unknownNCT00627029Not applicable
- The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD)Status unknownNCT00626613Phase 4
- Memantine - Communication StudyCompletedNCT00624026Phase 3
- Seroquel- Agitation Associated With DementiaCompletedNCT00621647Phase 3
- Safety Study of CTS21166 to Treat Alzheimer DiseaseCompletedNCT00621010Phase 1
- Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy SubjectsTerminatedNCT00612872Phase 1
- Effects of Delivery Mode of Cognition Intervention in Early Alzheimer's DiseaseCompletedNCT00611312Phase 2
- Treatment With Copper in Patients With Mild Alzheimer´s DementiaCompletedNCT00608946Phase 2
- A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's DiseaseCompletedNCT00607308Phase 1
- AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's DiseaseTerminatedNCT00606476Phase 2
- Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's DiseaseStatus unknownNCT00606164Phase 2
- Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy SubjectsTerminatedNCT00605059Phase 1
- Evaluation of [123I] AV151 and SPECT in Subjects w/ AD in Comparison to Healthy SubjectsTerminatedNCT00605046Phase 1
- Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's DiseaseTerminatedNCT00602680Phase 2
- Far Infrared Treatment for Alzheimer's DiseaseStatus unknownNCT00599469Phase 1
- Lutein and Alzheimer's Disease StudyTerminatedNCT00596024Phase 2
- The Impact of Lorazepam on Cognition in APOE e4 CarriersCompletedNCT00586430Not applicable
- Effect of AQW051 in Patients With Memory ImpairmentTerminatedNCT00582855Phase 2
- Evaluation of the COGNISION(TM) System as an Event-related Potential (ERP) Collection System.CompletedNCT00582127
- Safety Study of Nicotinamide to Treat Alzheimer's DiseaseCompletedNCT00580931Phase 1/2
- Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)CompletedNCT00575055Phase 3
- Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)CompletedNCT00574132Phase 3
- Risk Evaluation and Education for Alzheimer's DiseaseCompletedNCT00571025Not applicable
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's DiseaseCompletedNCT00566397Phase 2
- Study Evaluating Potential Pharmacokinetic (PK) Interaction Between Lecozotan and DigoxinCompletedNCT00563732Phase 1
- Meditation or Education for Alzheimer CaregiversCompletedNCT00558402Phase 2
- Evaluation of [123I] AV51 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy SubjectsCompletedNCT00556660Phase 1
- Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's DiseaseTerminatedNCT00555204Phase 2
- A Study To Assess The Pharmacokinetics Of SB-742457 Formulated As A Capsule And A Tablet In Healthy Elderly Volunteers.CompletedNCT00551772Phase 1
- Home-Based Assessment for Alzheimer Disease PreventionCompletedNCT00546767Not applicable
- Effects of a Complex Cognitive Training in Mild Cognitive Impairment and Mild Alzheimer's DiseaseCompletedNCT00544856Not applicable
- Evaluation of [123I] MNI-308 and SPECT as a Marker of Beta-amyloid Protein Deposition in AD Subjects Compared to HCTerminatedNCT00544453Phase 1
- PET Study of the Nicotinic Receptors in HumanTerminatedNCT00543322
- A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.CompletedNCT00531804Phase 1
- Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®)Status unknownNCT00523666Phase 4
- TRx0014 in Patients With Mild or Moderate Alzheimer's DiseaseCompletedNCT00515333Phase 2
- Memantine Versus Donepezil in Early Stages of Alzheimer's DiseaseCompletedNCT00505167Phase 4
- Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's DiseaseCompletedNCT00501111Phase 2
- Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's DiseaseTerminatedNCT00500500Phase 2